Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors

被引：374
|
作者：
Hecht, FM
Grant, RM
Petropoulos, CJ
Dillon, B
Chesney, MA
Tian, H
Hellmann, NS
Bandrapalli, NI
Digilio, L
Branson, B
Kahn, JO
机构：
[1] Univ Calif San Francisco, AIDS Program, San Francisco, CA 94110 USA
[2] San Francisco Gen Hosp, AIDS Program, San Francisco, CA 94110 USA
[3] Gladstone Inst Virol & Immunol, San Francisco, CA USA
[4] ViroLog, S San Francisco, CA USA
[5] Ctr Dis Control & Prevent, Atlanta, GA USA
[6] Univ Calif San Francisco, Ctr Aids Prevent Studies, San Francisco, CA USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1998年 / 339卷 / 05期
关键词：
D O I：
10.1056/NEJM199807303390504
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：307 / 311
页数：5
相关论文
共 50 条
  • [21] Fullerene derivatives as dual inhibitors of HIV-1 reverse transcriptase and protease
    Yasuno, Takumi
    Ohe, Tomoyuki
    Kataoka, Hiroki
    Hashimoto, Kosho
    Ishikawa, Yumiko
    Furukawa, Keigo
    Tateishi, Yasuhiro
    Kobayashi, Toi
    Takahashi, Kyoko
    Nakamura, Shigeo
    Mashino, Tadahiko
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 31
  • [22] ENHANCEMENT OF HIV-1 PROTEINASE ACTIVITY BY HIV-1 REVERSE-TRANSCRIPTASE
    GOOBARLARSSON, L
    LUUKKONEN, BGM
    UNGE, T
    SCHWARTZ, S
    UTTER, G
    STRANDBERG, B
    OBERG, B
    VIROLOGY, 1995, 206 (01) : 387 - 394
  • [23] HOW TO OVERCOME RESISTANCE OF HIV-1 TO HIV-1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS
    DECLERCQ, E
    AIDS, 1994, 8 (07) : 1020 - 1021
  • [24] HIV-1 reverse transcriptase inhibitors
    El Safadi, Yazan
    Vivet-Boudou, Valerie
    Marquet, Roland
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2007, 75 (04) : 723 - 737
  • [25] HIV-1 reverse transcriptase inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (03) : 122 - 122
  • [26] HIV-1 reverse transcriptase inhibitors
    Yazan El Safadi
    Valérie Vivet-Boudou
    Roland Marquet
    Applied Microbiology and Biotechnology, 2007, 75 : 723 - 737
  • [27] THE GENETIC AND FUNCTIONAL BASIS OF HIV-1 RESISTANCE TO NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS
    EMINI, EA
    BYRNES, VW
    CONDRA, JH
    SCHLEIF, WA
    SARDANA, VV
    ARCHIVES OF VIROLOGY, 1994, : 11 - 17
  • [28] THIADIAZOLE DERIVATIVES - HIGHLY POTENT AND SPECIFIC HIV-1 REVERSE-TRANSCRIPTASE INHIBITORS
    HANASAKI, Y
    WATANABE, H
    KATSUURA, K
    TAKAYAMA, H
    SHIRAKAWA, S
    YAMAGUCHI, K
    SAKAI, S
    IJICHI, K
    FUJIWARA, M
    KONNO, K
    YOKOTA, T
    SHIGETA, S
    BABA, M
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (12) : 2038 - 2040
  • [29] SUBSTITUTED NAPHTHALENONES AS A NEW STRUCTURAL CLASS OF HIV-1 REVERSE-TRANSCRIPTASE INHIBITORS
    ALAM, M
    BECHTOLD, CM
    PATICK, AK
    SKOOG, MT
    GANT, TG
    COLONNO, RJ
    MEYERS, AI
    LI, H
    TRIMBLE, J
    LIN, PF
    ANTIVIRAL RESEARCH, 1993, 22 (2-3) : 131 - 141
  • [30] TIBO DERIVATIVES ARE POTENT INHIBITORS OF HIV-1 REVERSE-TRANSCRIPTASE WITH HETEROPOLYMER TEMPLATES
    WHITE, EL
    BUCKHEIT, RW
    PARKER, WB
    ROSS, LJ
    GERMANY, JM
    SHANNON, WM
    CHIRIGOS, MA
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1991, 4 (03): : 359 - 359
12345